ARMATA PHARMACEUTICALS, INC. Severance Costs
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Severance Costs of $289.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2016-03-30
- ARMATA PHARMACEUTICALS, INC. severance costs for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. severance costs for the quarter ending 2015-09-30 was $289.00K, a 84.29% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. severance costs for the quarter ending 2014-12-31 was $24.00K.
- ARMATA PHARMACEUTICALS, INC. severance costs for the quarter ending 2014-09-30 was $1.84M.
- ARMATA PHARMACEUTICALS, INC. severance costs for fiscal 2015 was $289.00K, a 84.50% decline from fiscal 2014.
- ARMATA PHARMACEUTICALS, INC. severance costs for fiscal 2014 was $1.86M.
- ARMATA PHARMACEUTICALS, INC. severance costs for fiscal 2013 was $0.00.
| Period end | Severance Costs 3 month | Severance Costs 3 month as first filed | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 9 month as first filed | Severance Costs 12 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $289.00K derived: sum of 2 quarters · filed 2016-03-30 | $289.00K 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $289.00K 10-Q · filed 2015-11-16 | $289.00K 10-Q · filed 2015-11-16 | ||||
| 2014-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.86M derived: sum of 2 quarters · filed 2016-03-30 | $1.86M 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $1.84M 10-Q · filed 2015-11-16 | $1.51M 10-Q · filed 2014-11-14 | $1.84M 10-Q · filed 2015-11-16 | $1.51M 10-Q · filed 2014-11-14 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $0.00 10-K · filed 2015-04-15 | |||
| 2013-09-30 | $0.00 10-Q/A · filed 2015-04-15 | $0.00 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |